EB1
EB1 is the inhibitor of kinases MNK with IC50s of 0.69 μM (MNK1) and 9.4 μM (MNK2) . EB1 selectively inhibits the growth of cancer cells, but not normal cells. EB1 also increases cell apoptosis and suppresses eIF4E phosphorylation[1][2].
Product Specifications
CAS Number
42951-68-8
UNSPSC
12352005
Target
Apoptosis; Eukaryotic Initiation Factor (eIF) ; MNK
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/eb1.html
Purity
99.91
Solubility
DMSO : 8.33 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
NC1=NNC2=C1C(C3=CC=CC=C3)=CC(C4=CC=CC=C4)=N2
Molecular Formula
C18H14N4
Molecular Weight
286.33
References & Citations
[1]Bou-Petit E, et al. Overcoming Paradoxical Kinase Priming by a Novel MNK1 Inhibitor. J Med Chem. 2022 Apr 28;65 (8) :6070-6087. |[2]Aboukhatwa SM, et al. Nicotinonitrile-derived apoptotic inducers: Design, synthesis, X-ray crystal structure and Pim kinase inhibition. Bioorg Chem. 2022 Dec;129:106126.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
EIF4; MNK1; MNK2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6280742-01 0.2 mL
CAPN13, CT (CAPN13, Calpain-13, Calcium-activated neutral proteinase 13) (Azide free) (HRP)
Sign In for Pricing
View Details MBS6280742-02 5x 0.2 mL
CAPN13, CT (CAPN13, Calpain-13, Calcium-activated neutral proteinase 13) (Azide free) (HRP)
Sign In for Pricing
View Details 
